"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","29/45","481/2914",4.64539288544501e-13,2.16010769173193e-10,1.3936178656335e-10,"CREB1/EP300/HIPK2/MAPK14/MDM2/MYB/PML/RB1/SKI/SMAD3/TP53/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PPARGC1A/PRKAA1/PRKAA2/PTEN/SP1/STK11/FOXO4/FOXO3/TCF7L2/YY1/SREBF1/ESRRA/NR2C2",29
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","29/45","499/2914",1.24157984834546e-12,2.88667314740319e-10,1.86236977251819e-10,"CREB1/EP300/HIPK2/MAPK14/MDM2/MYB/PML/RB1/SKI/SMAD3/TP53/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PPARGC1A/PRKAA1/PRKAA2/PTEN/SP1/STK11/FOXO4/FOXO3/TCF7L2/YY1/SREBF1/ESRRA/NR2C2",29
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","9/45","49/2914",2.8141635646635e-08,4.27151493126614e-06,2.75581608468783e-06,"EP300/SMAD3/AKT3/CDKN1A/PPARGC1A/STK11/FOXO4/FOXO3/SREBF1",9
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","7/45","24/2914",3.67442144625044e-08,4.27151493126614e-06,2.75581608468783e-06,"CREB1/MDM2/AKT3/CDKN1A/GSK3B/FOXO4/FOXO3",7
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","21/45","397/2914",6.51537257979543e-08,6.05929649920975e-06,3.90922354787726e-06,"CREB1/EP300/MAPK14/MYB/PML/SMAD3/PLCG1/SIAH2/VAV2/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PAK1/PPARGC1A/FOXO3/YY1/CEBPB/STAT3/SREBF1",21
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","7/45","27/2914",9.10730650938118e-08,7.05816254477042e-06,4.55365325469059e-06,"CREB1/EP300/MYB/PML/CDKN1A/CEBPB/STAT3",7
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","17/45","268/2914",1.51822724787415e-07,1.00853667180211e-05,6.50668820517493e-06,"CREB1/CTBP1/EP300/MDM2/SMAD3/PLCG1/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PTEN/FOXO4/FOXO3/TCF7L2/STAT5A/STAT3",17
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/45","23/2914",7.98399817941921e-07,4.64069894178742e-05,2.99399931728221e-05,"MDM2/RB1/TP53/MAPK1/MAPK3/SP1",6
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","10/45","95/2914",1.04582445315565e-06,5.4034263413042e-05,3.48608151051884e-05,"EP300/HIPK2/MAPK14/MDM2/PML/TP53/AKT3/PRKAA1/PRKAA2/STK11",10
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","10/45","99/2914",1.54159987395703e-06,7.16843941390018e-05,4.62479962187108e-05,"MAPK14/MDM2/RB1/TP53/CDKN1A/MAPK1/MAPK3/SP1/CEBPB/STAT3",10
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/45","62/2914",3.07835560236686e-06,0.000130130486827326,8.39551527918235e-05,"RB1/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PPARGC1A/ESRRA",8
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","10/45","108/2914",3.4630194705234e-06,0.000134192004482782,8.65754867630849e-05,"CREB1/EP300/MYB/AKT3/MAPK1/MAPK3/SP1/FOXO3/YY1/FOXA1",10
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","11/45","136/2914",3.97358089303404e-06,0.000142131931943141,9.16980206084778e-05,"CREB1/EP300/MYB/AKT3/MAPK1/MAPK3/SP1/FOXO3/YY1/FOXA1/SREBF1",11
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","7/45","47/2914",5.12028947429022e-06,0.000170066757538925,0.00010972048873479,"EP300/ARNTL/PPARGC1A/SP1/CLOCK/SREBF1/ESRRA",7
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","13/45","201/2914",5.54712133866402e-06,0.000171960761498585,0.000110942426773281,"CREB1/MDM2/PML/TP53/PLCG1/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PTEN/FOXO4/FOXO3",13
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","7/45","48/2914",5.92561425662952e-06,0.000172213164333295,0.000111105267311803,"EP300/ARNTL/PPARGC1A/SP1/CLOCK/SREBF1/ESRRA",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","12/45","172/2914",6.34390054861349e-06,0.000173524338535604,0.000111951186152003,"CREB1/MDM2/PML/TP53/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PTEN/FOXO4/FOXO3",12
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","5/45","19/2914",6.92885984943958e-06,0.000178995546110522,0.00011548099749066,"SMAD3/PPARGC1A/FOXO4/FOXO3/SREBF1",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","7/45","52/2914",1.0280421887657e-05,0.000251599798829501,0.000162322450857743,"CREB1/EP300/ARNTL/PPARGC1A/BHLHE40/CLOCK/SREBF1",7
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/45","53/2914",1.17086804938654e-05,0.00027222682148237,0.00017563020740798,"EP300/MDM2/SMAD3/TP53/CDKN1A/FOXO3/TCF7L2",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","12/45","187/2914",1.51494077197847e-05,0.00033545117093809,0.000216420110282639,"EP300/MAPK14/MDM2/RB1/TP53/CDKN1A/GSK3B/MAPK1/MAPK3/SP1/CEBPB/STAT3",12
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","12/45","189/2914",1.69025203321712e-05,0.000344014203597817,0.000221944647482463,"EP300/MAPK14/MDM2/RB1/TP53/CDKN1A/GSK3B/MAPK1/MAPK3/SP1/CEBPB/STAT3",12
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","7/45","56/2914",1.70157563069888e-05,0.000344014203597817,0.000221944647482463,"HIPK2/MAPK14/MDM2/TP53/PRKAA1/PRKAA2/STK11",7
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","12/45","194/2914",2.20870787200068e-05,0.000427937150200131,0.000276088484000085,"EP300/HIPK2/MAPK14/MDM2/PML/TP53/AKT3/CDKN1A/PRKAA1/PRKAA2/PTEN/STK11",12
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/45","24/2914",2.39099705508893e-05,0.000444725452246541,0.000286919646610671,"CREB1/AKT3/MAPK1/MAPK3/FOXO3",5
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/45","13/2914",3.20887935209509e-05,0.000552640332860822,0.000356542150232788,"MDM2/AKT3/CDKN1A/GSK3B",4
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","4/45","13/2914",3.20887935209509e-05,0.000552640332860822,0.000356542150232788,"EP300/STK11/FOXO4/FOXO3",4
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/45","14/2914",4.44188415458117e-05,0.000712233148924223,0.000459505257370466,"EP300/PML/TP53/AKT3",4
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","4/45","14/2914",4.44188415458117e-05,0.000712233148924223,0.000459505257370466,"SMAD3/CDKN1A/FOXO4/FOXO3",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","9/45","119/2914",5.9753805076071e-05,0.0009261839786791,0.00059753805076071,"EP300/ARNTL/PPARGC1A/PRKAA2/PTEN/SP1/CLOCK/SREBF1/ESRRA",9
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","5/45","30/2914",7.48140240185001e-05,0.0011222103602775,0.000724006684050001,"PLCG1/VAV2/MAPK1/MAPK3/PAK1",5
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","8/45","97/2914",8.79586145719783e-05,0.00127814861799906,0.000824612011612297,"CREB1/MDM2/AKT3/CDKN1A/GSK3B/PTEN/FOXO4/FOXO3",8
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","5/45","35/2914",0.000160897995000916,0.00221328872585715,0.00142792821023042,"TP53/AKT3/PRKAA1/PRKAA2/PTEN",5
"R-HSA-1643685","R-HSA-1643685","Disease","17/45","443/2914",0.000161831863826115,0.00221328872585715,0.00142792821023042,"CREB1/CTBP1/EP300/MDM2/SMAD3/PLCG1/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3/PTEN/FOXO4/FOXO3/TCF7L2/STAT5A/STAT3",17
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/45","20/2914",0.000200892324806763,0.00266899802957556,0.0017219342126294,"VAV2/MAPK1/MAPK3/PAK1",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","6/45","59/2914",0.00023488255919941,0.00302046611723834,0.00194868781757312,"PML/TP53/AKT3/MAPK1/MAPK3/PTEN",6
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","5/45","38/2914",0.000240338164167352,0.00302046611723834,0.00194868781757312,"CREB1/MAPK14/PPARGC1A/PRKAA2/ESRRA",5
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/45","10/2914",0.000383057084808407,0.00456721908810023,0.00294659296006467,"MAPK14/MAPK1/MAPK3",3
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","3/45","10/2914",0.000383057084808407,0.00456721908810023,0.00294659296006467,"EP300/FOXO4/FOXO3",3
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/45","24/2914",0.000421131944731344,0.00477625254390427,0.00308145325413179,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/45","24/2914",0.000421131944731344,0.00477625254390427,0.00308145325413179,"MAPK1/MAPK3/STAT5A/STAT3",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/45","44/2914",0.000485324630260107,0.00530390132637181,0.00342187182346568,"MAPK14/MDM2/TP53/MAPK1/MAPK3",5
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","8/45","124/2914",0.000490468294696748,0.00530390132637181,0.00342187182346568,"EP300/MDM2/SMAD3/TP53/SIAH2/PTEN/FOXO4/YY1",8
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/45","11/2914",0.000521022502528602,0.00550626053808636,0.0035524261536041,"AKT3/FOXO4/FOXO3",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/45","45/2914",0.000539748298970538,0.00557739908936223,0.00359832199313692,"CDKN1A/MAPK1/MAPK3/CEBPB/STAT3",5
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/45","70/2914",0.000601714645293226,0.006082550218725,0.00392422594756452,"CREB1/MAPK14/PLCG1/MAPK1/MAPK3/STAT3",6
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/45","47/2914",0.000662259117057129,0.00655213807301202,0.00422718585355614,"CREB1/MAPK1/MAPK3/PRKAA1/PRKAA2",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","5/45","49/2914",0.00080456286354153,0.00748243463093623,0.00482737718124918,"TP53/AKT3/MAPK1/MAPK3/STAT3",5
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/45","49/2914",0.00080456286354153,0.00748243463093623,0.00482737718124918,"CREB1/MAPK1/MAPK3/PRKAA1/PRKAA2",5
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","5/45","49/2914",0.00080456286354153,0.00748243463093623,0.00482737718124918,"EP300/MYB/SP1/YY1/FOXA1",5
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","3/45","13/2914",0.000883742824952407,0.00805765516868371,0.00519848720560239,"EP300/MDM2/TP53",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","6/45","77/2914",0.00100329985105999,0.00890546693459884,0.00574546253845087,"CREB1/MDM2/MAPK1/MAPK3/PRKAA1/PRKAA2",6
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","4/45","30/2914",0.00101503171512632,0.00890546693459884,0.00574546253845087,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","7/45","107/2914",0.00105935392195427,0.00912221432793956,0.00588529956641262,"CTBP1/EP300/HIPK2/MDM2/PML/TP53/PPARGC1A",7
"R-HSA-2990846","R-HSA-2990846","SUMOylation","7/45","109/2914",0.001182722358354,0.00999937993881108,0.00645121286374909,"CTBP1/EP300/HIPK2/MDM2/PML/TP53/PPARGC1A",7
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","6/45","80/2914",0.00122817191100305,0.0101982131895789,0.00657949238037349,"MDM2/SMAD3/TP53/SIAH2/PTEN/FOXO4",6
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/45","16/2914",0.00167512026873237,0.0136654548238693,0.00881642246701248,"MAPK14/MAPK1/MAPK3",3
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","4/45","35/2914",0.00183308378560515,0.0146962751776964,0.00948146785657835,"MAPK14/PLCG1/SIAH2/PAK1",4
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","6/45","88/2914",0.00201884622336584,0.0159112456587308,0.0102653197798263,"CREB1/MDM2/MAPK1/MAPK3/PRKAA1/PRKAA2",6
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/45","89/2914",0.00213985056711959,0.0165838418951768,0.0106992528355979,"CREB1/MAPK14/PLCG1/MAPK1/MAPK3/STAT3",6
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/45","37/2914",0.00226070612302693,0.0172332515935659,0.0111182268345587,"CTBP1/EP300/HIPK2/PPARGC1A",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","5/45","62/2914",0.00235156007158935,0.0173552704455647,0.0111969486745579,"PLCG1/VAV2/MAPK1/MAPK3/PAK1",5
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","3/45","18/2914",0.00238868238390568,0.0173552704455647,0.0111969486745579,"PRKAA1/PRKAA2/STK11",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/45","18/2914",0.00238868238390568,0.0173552704455647,0.0111969486745579,"CREB1/MAPK1/MAPK3",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","5/45","63/2914",0.00252512928273814,0.0180643864072806,0.0116544428434068,"CREB1/AKT3/MAPK1/MAPK3/FOXO3",5
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","3/45","19/2914",0.0028060840064898,0.019475060642056,0.0125645552529394,"ARNTL/BHLHE40/CLOCK",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/45","19/2914",0.0028060840064898,0.019475060642056,0.0125645552529394,"RB1/MAPK1/MAPK3",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","4/45","40/2914",0.00302443489222621,0.0206817974247821,0.0133430951127627,"EP300/PPARGC1A/CEBPB/SREBF1",4
"R-HSA-1430728","R-HSA-1430728","Metabolism","11/45","289/2914",0.00351495899441866,0.0236877671362997,0.0152824304105159,"EP300/PLCG1/ARNTL/PPARGC1A/PRKAA2/PTEN/SP1/STK11/CLOCK/SREBF1/ESRRA",11
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","3/45","21/2914",0.00376923216496992,0.0250384708101573,0.0161538521355854,"MAPK14/MAPK1/MAPK3",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/45","43/2914",0.00394864900274211,0.0258608702292265,0.0166844324059526,"VAV2/MAPK1/MAPK3/PAK1",4
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/45","22/2914",0.00431755329049663,0.027130571352445,0.0175035944209323,"CREB1/MAPK1/MAPK3",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/45","22/2914",0.00431755329049663,0.027130571352445,0.0175035944209323,"MDM2/TP53/CDKN1A",3
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/45","22/2914",0.00431755329049663,0.027130571352445,0.0175035944209323,"MDM2/TP53/CDKN1A",3
"R-HSA-112316","R-HSA-112316","Neuronal System","6/45","105/2914",0.00492358072224765,0.0305262004779355,0.0196943228889906,"CREB1/MDM2/MAPK1/MAPK3/PRKAA1/PRKAA2",6
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/45","24/2914",0.00555349205557088,0.0331073564851341,0.0213595848291188,"RB1/TP53/CDKN1A",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/45","24/2914",0.00555349205557088,0.0331073564851341,0.0213595848291188,"MDM2/TP53/CDKN1A",3
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/45","24/2914",0.00555349205557088,0.0331073564851341,0.0213595848291188,"RB1/MAPK1/MAPK3",3
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","3/45","25/2914",0.0062431882617208,0.0362885317712522,0.023411955981453,"VAV2/AKT3/PAK1",3
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/45","25/2914",0.0062431882617208,0.0362885317712522,0.023411955981453,"EP300/CDKN1A/YY1",3
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/45","49/2914",0.00633752734018002,0.0363821013973297,0.0234723234821482,"EP300/GSK3B/MAPK1/MAPK3",4
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","3/45","26/2914",0.00698195942479396,0.0395928186893804,0.0255437539931486,"GSK3B/PPARGC1A/ESRRA",3
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","5/45","80/2914",0.00710684932379248,0.0398154811513675,0.0256874071944306,"CREB1/MAPK14/PPARGC1A/PRKAA2/ESRRA",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","8/45","191/2914",0.00774728338842627,0.0425100572390227,0.0274258433800147,"EP300/RB1/TP53/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3",8
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/45","27/2914",0.00777065562433748,0.0425100572390227,0.0274258433800147,"PRKAA1/PRKAA2/STK11",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/45","53/2914",0.00837463721052307,0.0452814686382934,0.0292138507343828,"VAV2/MAPK1/MAPK3/PAK1",4
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","5/45","85/2914",0.00915739079077901,0.0469869689639986,0.0303141735251604,"MAPK14/PLCG1/VAV2/AKT3/PAK1",5
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","3/45","29/2914",0.00950086947963277,0.0469869689639986,0.0303141735251604,"PLCG1/STAT5A/STAT3",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/45","29/2914",0.00950086947963277,0.0469869689639986,0.0303141735251604,"MDM2/TP53/AKT3",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/45","29/2914",0.00950086947963277,0.0469869689639986,0.0303141735251604,"MDM2/TP53/AKT3",3
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"MAPK1/MAPK3",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"EP300/GSK3B",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"TP53/AKT3",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"MAPK1/MAPK3",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"STAT5A/STAT3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/45","10/2914",0.00970053552805132,0.0469869689639986,0.0303141735251604,"MAPK1/MAPK3",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","5/45","87/2914",0.0100820669228522,0.0483315579291367,0.0311816502768624,"PLCG1/VAV2/MAPK1/MAPK3/PAK1",5
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/45","30/2914",0.0104437403423557,0.0495544822366879,0.031970633701089,"EP300/TP53/CDKN1A",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/45","31/2914",0.0114392471998423,0.0524932567293066,0.0338666172447139,"CTBP1/GSK3B/TCF7L2",3
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","3/45","31/2914",0.0114392471998423,0.0524932567293066,0.0338666172447139,"PLCG1/STAT5A/STAT3",3
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/45","11/2914",0.0117404273115008,0.0524932567293066,0.0338666172447139,"CREB1/EP300",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/45","11/2914",0.0117404273115008,0.0524932567293066,0.0338666172447139,"STAT5A/STAT3",2
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","2/45","11/2914",0.0117404273115008,0.0524932567293066,0.0338666172447139,"CEBPB/ATF3",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/45","11/2914",0.0117404273115008,0.0524932567293066,0.0338666172447139,"TP53/CDKN1A",2
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","9/45","249/2914",0.0120455627942728,0.0532740978805665,0.0343703857293978,"EP300/MDM2/RB1/TP53/AKT3/CDKN1A/GSK3B/MAPK1/MAPK3",9
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","3/45","32/2914",0.0124879068150145,0.0532740978805665,0.0343703857293978,"CREB1/PPARGC1A/ESRRA",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/45","32/2914",0.0124879068150145,0.0532740978805665,0.0343703857293978,"GSK3B/MAPK1/MAPK3",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/45","32/2914",0.0124879068150145,0.0532740978805665,0.0343703857293978,"CREB1/MAPK1/MAPK3",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/45","32/2914",0.0124879068150145,0.0532740978805665,0.0343703857293978,"TP53/MAPK1/MAPK3",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","5/45","92/2914",0.0126724329853682,0.0535698303472383,0.034561180869186,"MAPK14/PLCG1/VAV2/AKT3/PAK1",5
"R-HSA-450294","R-HSA-450294","MAP kinase activation","4/45","60/2914",0.0128948242415737,0.0540188583092951,0.0348508763285775,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","12/45","393/2914",0.0133083623846003,0.054514690444104,0.0351707680284542,"CTBP1/EP300/HIPK2/MDM2/PML/SMAD3/TP53/SIAH2/PPARGC1A/PTEN/FOXO4/YY1",12
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/45","33/2914",0.0135901759085474,0.054514690444104,0.0351707680284542,"MAPK14/MAPK1/MAPK3",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/45","33/2914",0.0135901759085474,0.054514690444104,0.0351707680284542,"RB1/MAPK1/MAPK3",3
"R-HSA-422475","R-HSA-422475","Axon guidance","9/45","254/2914",0.0136297044872607,0.054514690444104,0.0351707680284542,"CREB1/MAPK14/PLCG1/SIAH2/VAV2/GSK3B/MAPK1/MAPK3/PAK1",9
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/45","12/2914",0.0139510713179535,0.054514690444104,0.0351707680284542,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/45","12/2914",0.0139510713179535,0.054514690444104,0.0351707680284542,"MAPK1/MAPK3",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/45","12/2914",0.0139510713179535,0.054514690444104,0.0351707680284542,"STAT5A/STAT3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/45","12/2914",0.0139510713179535,0.054514690444104,0.0351707680284542,"MAPK1/MAPK3",2
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","4/45","64/2914",0.0160669299667883,0.0622297654916715,0.0401482358010784,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/45","13/2914",0.0163269492257719,0.0622297654916715,0.0401482358010784,"EP300/SREBF1",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/45","13/2914",0.0163269492257719,0.0622297654916715,0.0401482358010784,"MAPK1/MAPK3",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/45","36/2914",0.0172223499264735,0.0651088838683753,0.0420057315279841,"SKI/SMAD3/SP1",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/45","101/2914",0.0184164397563975,0.0674703048394264,0.0435292289286622,"TP53/AKT3/MAPK1/MAPK3/STAT3",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/45","37/2914",0.018542494967954,0.0674703048394264,0.0435292289286622,"CTBP1/GSK3B/TCF7L2",3
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/45","37/2914",0.018542494967954,0.0674703048394264,0.0435292289286622,"PLCG1/MAPK1/MAPK3",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/45","14/2914",0.0188626658690869,0.0674703048394264,0.0435292289286622,"MAPK1/MAPK3",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/45","14/2914",0.0188626658690869,0.0674703048394264,0.0435292289286622,"SP1/SREBF1",2
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","2/45","14/2914",0.0188626658690869,0.0674703048394264,0.0435292289286622,"CEBPB/ATF3",2
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","2/45","14/2914",0.0188626658690869,0.0674703048394264,0.0435292289286622,"STAT5A/STAT3",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/45","103/2914",0.0198942984575519,0.0701646370143993,0.0452675077512253,"TP53/AKT3/MAPK1/MAPK3/STAT3",5
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/45","38/2914",0.0199177034105391,0.0701646370143993,0.0452675077512253,"PLCG1/MAPK1/MAPK3",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/45","39/2914",0.0213481135828355,0.072624060155924,0.0468542323586607,"RB1/AKT3/CDKN1A",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/45","15/2914",0.0215529468849839,0.072624060155924,0.0468542323586607,"SMAD3/FOXO3",2
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/45","15/2914",0.0215529468849839,0.072624060155924,0.0468542323586607,"EP300/GSK3B",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/45","15/2914",0.0215529468849839,0.072624060155924,0.0468542323586607,"EP300/TP53",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/45","15/2914",0.0215529468849839,0.072624060155924,0.0468542323586607,"MDM2/TP53",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/45","15/2914",0.0215529468849839,0.072624060155924,0.0468542323586607,"SMAD3/STAT3",2
"R-HSA-69242","R-HSA-69242","S Phase","4/45","71/2914",0.0227237601819798,0.0758408930436455,0.0489296084152552,"RB1/AKT3/CDKN1A/GSK3B",4
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/45","40/2914",0.0228338172604524,0.0758408930436455,0.0489296084152552,"RB1/AKT3/CDKN1A",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/45","41/2914",0.0243748614002947,0.0776888762105476,0.0501218556197081,"PLCG1/MAPK1/MAPK3",3
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","3/45","41/2914",0.0243748614002947,0.0776888762105476,0.0501218556197081,"CREB1/HIPK2/PTEN",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/45","16/2914",0.0243926364015913,0.0776888762105476,0.0501218556197081,"MAPK1/MAPK3",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/45","16/2914",0.0243926364015913,0.0776888762105476,0.0501218556197081,"MDM2/TP53",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/45","16/2914",0.0243926364015913,0.0776888762105476,0.0501218556197081,"TP53/CDKN1A",2
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","2/45","16/2914",0.0243926364015913,0.0776888762105476,0.0501218556197081,"EP300/MDM2",2
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","10/45","332/2914",0.0266960906250145,0.084446817283209,0.0544818176020703,"CREB1/MAPK14/SMAD3/TP53/CDKN1A/MAPK1/MAPK3/FOXO3/STAT5A/STAT3",10
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/45","17/2914",0.027376694766409,0.0854373360159743,0.0551208619457898,"MDM2/PML",2
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/45","17/2914",0.027376694766409,0.0854373360159743,0.0551208619457898,"EP300/SMAD3",2
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","2/45","18/2914",0.0305001963142219,0.0931770593516573,0.0601142318397789,"PLCG1/PAK1",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/45","18/2914",0.0305001963142219,0.0931770593516573,0.0601142318397789,"EP300/HIPK2",2
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","4/45","78/2914",0.0308586390110865,0.0931770593516573,0.0601142318397789,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","4/45","78/2914",0.0308586390110865,0.0931770593516573,0.0601142318397789,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","4/45","78/2914",0.0308586390110865,0.0931770593516573,0.0601142318397789,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","3/45","45/2914",0.0310919064323545,0.0932757192970634,0.0601778834174602,"PLCG1/STAT5A/STAT3",3
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/45","19/2914",0.0337583271739551,0.100625782922366,0.0649198599499136,"EP300/PAK1",2
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","10/45","347/2914",0.0350575574360089,0.103832893042956,0.0669889632535202,"CREB1/MAPK14/PLCG1/VAV2/AKT3/MAPK1/MAPK3/PAK1/STAT5A/STAT3",10
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/45","20/2914",0.0371463831138365,0.108635648729144,0.0700875153091255,"SP1/SREBF1",2
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/45","20/2914",0.0371463831138365,0.108635648729144,0.0700875153091255,"SKI/SMAD3",2
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","4/45","83/2914",0.0376057172585631,0.109291615782699,0.0705107198598058,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/45","49/2914",0.0386876136383727,0.111400608109551,0.0718713600706781,"PLCG1/STAT5A/STAT3",3
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","4/45","84/2914",0.0390501056384018,0.111400608109551,0.0718713600706781,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","4/45","84/2914",0.0390501056384018,0.111400608109551,0.0718713600706781,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","2/45","21/2914",0.0406597674242435,0.114762681975397,0.0740404399841273,"AKT3/PAK1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/45","50/2914",0.04072224199127,0.114762681975397,0.0740404399841273,"PLCG1/MAPK1/MAPK3",3
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","4/45","86/2914",0.0420343025794934,0.115656513014582,0.0746171051706984,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","4/45","86/2914",0.0420343025794934,0.115656513014582,0.0746171051706984,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","4/45","86/2914",0.0420343025794934,0.115656513014582,0.0746171051706984,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/45","86/2914",0.0420343025794934,0.115656513014582,0.0746171051706984,"EP300/HIPK2/MYB/PML",4
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","4/45","87/2914",0.0435741693581267,0.117026731872116,0.0755011173368492,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","4/45","87/2914",0.0435741693581267,0.117026731872116,0.0755011173368492,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","4/45","87/2914",0.0435741693581267,0.117026731872116,0.0755011173368492,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/45","22/2914",0.0442939888376182,0.117026731872116,0.0755011173368492,"STAT5A/STAT3",2
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/45","22/2914",0.0442939888376182,0.117026731872116,0.0755011173368492,"EP300/TCF7L2",2
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","2/45","22/2914",0.0442939888376182,0.117026731872116,0.0755011173368492,"CREB1/HIPK2",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/45","22/2914",0.0442939888376182,0.117026731872116,0.0755011173368492,"EP300/SREBF1",2
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/45","23/2914",0.048044659484847,0.124994451598212,0.0806415816762659,"MAPK1/MAPK3",2
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/45","23/2914",0.048044659484847,0.124994451598212,0.0806415816762659,"EP300/TP53",2
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","4/45","90/2914",0.0483849490057595,0.124994451598212,0.0806415816762659,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","4/45","90/2914",0.0483849490057595,0.124994451598212,0.0806415816762659,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/45","55/2914",0.0516935389310587,0.128388213790912,0.082831105671556,"PLCG1/MAPK1/MAPK3",3
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"STAT5A/STAT3",2
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"EP300/AKT3",2
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"PLCG1/VAV2",2
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"SMAD3/SP1",2
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"PLCG1/VAV2",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"STAT5A/STAT3",2
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","2/45","24/2914",0.0519074928875084,0.128388213790912,0.082831105671556,"PLCG1/STAT5A",2
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","4/45","94/2914",0.0552446873340877,0.135330262620898,0.0873098468521922,"TP53/CDKN1A/FOXO3/STAT3",4
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/45","25/2914",0.055878301985403,0.135330262620898,0.0873098468521922,"MAPK1/MAPK3",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/45","25/2914",0.055878301985403,0.135330262620898,0.0873098468521922,"MAPK1/MAPK3",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/45","25/2914",0.055878301985403,0.135330262620898,0.0873098468521922,"AKT3/PTEN",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/45","26/2914",0.0599529971987871,0.144446340401223,0.0931911873556276,"CREB1/MAPK1",2
"R-HSA-202403","R-HSA-202403","TCR signaling","3/45","59/2914",0.0614035150253048,0.147178528282303,0.0949538892143889,"PLCG1/PAK1/PTEN",3
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/45","60/2914",0.0639566040139223,0.149845863336711,0.0966747505398137,"RB1/AKT3/CDKN1A",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/45","27/2914",0.0641275845247431,0.149845863336711,0.0966747505398137,"EP300/YY1",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/45","27/2914",0.0641275845247431,0.149845863336711,0.0966747505398137,"EP300/YY1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/45","27/2914",0.0641275845247431,0.149845863336711,0.0966747505398137,"MAPK1/MAPK3",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/45","27/2914",0.0641275845247431,0.149845863336711,0.0966747505398137,"TP53/PTEN",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/45","99/2914",0.0645302443445729,0.150032818101132,0.0967953665168593,"AKT3/MAPK1/MAPK3/PTEN",4
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/45","28/2914",0.0683981636671255,0.15745121834264,0.1015814311888,"MAPK1/MAPK3",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/45","28/2914",0.0683981636671255,0.15745121834264,0.1015814311888,"SP1/SREBF1",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/45","63/2914",0.0719086142242424,0.162662647513378,0.104943643557018,"SKI/SMAD3/SP1",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/45","29/2914",0.0727609261995324,0.162662647513378,0.104943643557018,"TP53/AKT3",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/45","29/2914",0.0727609261995324,0.162662647513378,0.104943643557018,"EP300/TP53",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/45","29/2914",0.0727609261995324,0.162662647513378,0.104943643557018,"CREB1/EP300",2
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","2/45","29/2914",0.0727609261995324,0.162662647513378,0.104943643557018,"PLCG1/VAV2",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","2/45","29/2914",0.0727609261995324,0.162662647513378,0.104943643557018,"CEBPB/ATF3",2
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","4/45","104/2914",0.0745943157478181,0.165963429773854,0.10707318049926,"CREB1/EP300/SMAD3/TP53",4
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/45","30/2914",0.0772121537607593,0.169356846692231,0.109262481736923,"CREB1/PLCG1",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/45","30/2914",0.0772121537607593,0.169356846692231,0.109262481736923,"TP53/STAT3",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/45","30/2914",0.0772121537607593,0.169356846692231,0.109262481736923,"MAPK1/MAPK3",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/45","66/2914",0.0802873648197218,0.175275233057139,0.113080795520735,"EP300/TP53/CDKN1A",3
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/45","31/2914",0.0817482162822018,0.175985743385295,0.113539189280836,"CTBP1/TCF7L2",2
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","2/45","31/2914",0.0817482162822018,0.175985743385295,0.113539189280836,"AKT3/PAK1",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/45","31/2914",0.0817482162822018,0.175985743385295,0.113539189280836,"TP53/STAT3",2
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","4/45","108/2914",0.083194377224802,0.178273665481719,0.115015268052722,"CTBP1/EP300/GSK3B/TCF7L2",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/45","68/2914",0.0861019834410994,0.182545409839576,0.117771232154565,"EP300/TP53/CDKN1A",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/45","32/2914",0.086365570246681,0.182545409839576,0.117771232154565,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/45","32/2914",0.086365570246681,0.182545409839576,0.117771232154565,"MAPK1/MAPK3",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","4/45","110/2914",0.0876735103704185,0.184471413222826,0.119013814982469,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"CREB1/MAPK1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"CREB1/MAPK1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"PLCG1/MAPK3",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"EP300/CLOCK",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"MAPK1/MAPK3",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"MAPK1/MAPK3",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/45","34/2914",0.0958304009619378,0.195443580909215,0.126092632844655,"PAK1/FOXO3",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/45","35/2914",0.100671208194534,0.204419702229075,0.131883678857468,"PLCG1/MAPK3",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/45","37/2914",0.110553534254403,0.223510406209988,0.14420026207096,"EP300/GSK3B",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/45","77/2914",0.114377651373214,0.230240726790237,0.148542404380798,"RB1/AKT3/CDKN1A",3
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/45","38/2914",0.115588858190173,0.231675944217372,0.149468351107982,"GSK3B/PAK1",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/45","172/2914",0.12298701626045,0.245446191249395,0.158352381451223,"CTBP1/EP300/NLK/GSK3B/TCF7L2",5
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/45","40/2914",0.12583290697921,0.246887349136425,0.159282160733177,"NLK/TCF7L2",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/45","40/2914",0.12583290697921,0.246887349136425,0.159282160733177,"RB1/CDKN1A",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/45","40/2914",0.12583290697921,0.246887349136425,0.159282160733177,"RB1/CDKN1A",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/45","40/2914",0.12583290697921,0.246887349136425,0.159282160733177,"EP300/SMAD3",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","4/45","127/2914",0.13028704793254,0.253882024621406,0.163794854594456,"CREB1/MAPK14/MAPK1/MAPK3",4
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/45","41/2914",0.131035883675565,0.253882024621406,0.163794854594456,"STAT5A/STAT3",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/45","41/2914",0.131035883675565,0.253882024621406,0.163794854594456,"STAT5A/STAT3",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/45","42/2914",0.136289115367855,0.259731305926446,0.167568584468675,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/45","42/2914",0.136289115367855,0.259731305926446,0.167568584468675,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/45","42/2914",0.136289115367855,0.259731305926446,0.167568584468675,"MAPK1/MAPK3",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/45","42/2914",0.136289115367855,0.259731305926446,0.167568584468675,"MAPK1/MAPK3",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","4/45","130/2914",0.138591907036346,0.263041782742452,0.169704375962873,"MAPK14/MAPK1/MAPK3/PAK1",4
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/45","10/2914",0.144333393235718,0.269538264476341,0.173895654500865,"MAPK3",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/45","10/2914",0.144333393235718,0.269538264476341,0.173895654500865,"RB1",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/45","10/2914",0.144333393235718,0.269538264476341,0.173895654500865,"CREB1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/45","10/2914",0.144333393235718,0.269538264476341,0.173895654500865,"STAT3",1
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/45","86/2914",0.145718665674136,0.271036718153894,0.174862398808964,"SKI/SMAD3/SP1",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","2/45","44/2914",0.146935620129889,0.272211407810352,0.175620263103453,"PLCG1/AKT3",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"STAT3",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"RB1",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"AKT3",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"AKT3",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"PLCG1",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"TP53",1
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"STAT3",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"PAK1",1
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"PLCG1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"TP53",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"GSK3B",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"YY1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"PRKAA2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/45","11/2914",0.15759268982814,0.273710876732803,0.17658766240826,"STAT3",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/45","46/2914",0.157751645084712,0.273710876732803,0.17658766240826,"ESRRA/NR2C2",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/45","46/2914",0.157751645084712,0.273710876732803,0.17658766240826,"MAPK1/MAPK3",2
"R-HSA-109582","R-HSA-109582","Hemostasis","7/45","298/2914",0.170327731668332,0.284418364639352,0.183495719122163,"MAPK14/MYB/TP53/PLCG1/VAV2/MAPK1/MAPK3",7
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"CREB1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"SMAD3",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"HIPK2",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"EP300",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"TCF7L2",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"PAK1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"CREB1",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"STAT5A",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/45","12/2914",0.170651018783611,0.284418364639352,0.183495719122163,"CREB1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/45","49/2914",0.174250642267464,0.289263665863544,0.186621719911964,"MAPK1/MAPK3",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"CREB1",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"MAPK14",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"PAK1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"GSK3B",1
"R-HSA-5654227","R-HSA-5654227","Phospholipase C-mediated cascade; FGFR3","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"PLCG1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"SP1",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"AKT3",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"EP300",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/45","13/2914",0.183511357913431,0.289263665863544,0.186621719911964,"PAK1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/45","97/2914",0.187391953052472,0.292172628241608,0.188498469833295,"PML/PLCG1/MAPK3",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/45","52/2914",0.191024478779041,0.292172628241608,0.188498469833295,"MAPK1/MAPK3",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/45","52/2914",0.191024478779041,0.292172628241608,0.188498469833295,"MAPK1/MAPK3",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"TCF7L2",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"PAK1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"GSK3B",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"PLCG1",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"PLCG1",1
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"PLCG1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/45","14/2914",0.196176641916843,0.292172628241608,0.188498469833295,"EP300",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/45","53/2914",0.196666736859405,0.292172628241608,0.188498469833295,"PRKAA1/PRKAA2",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","2/45","53/2914",0.196666736859405,0.292172628241608,0.188498469833295,"AKT3/PAK1",2
"R-HSA-397014","R-HSA-397014","Muscle contraction","2/45","53/2914",0.196666736859405,0.292172628241608,0.188498469833295,"HIPK2/PAK1",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/45","55/2914",0.208015502646865,0.300483742823651,0.193860479241065,"PRKAA2/STK11",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/45","55/2914",0.208015502646865,0.300483742823651,0.193860479241065,"EP300/YY1",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"AKT3",1
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"STAT5A",1
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"PTEN",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"MAPK14",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"FOXO3",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/45","15/2914",0.208649762990547,0.300483742823651,0.193860479241065,"FOXO3",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/45","153/2914",0.20872311598288,0.300483742823651,0.193860479241065,"MAPK14/VAV2/MAPK1/MAPK3",4
"R-HSA-68886","R-HSA-68886","M Phase","3/45","105/2914",0.219493517843099,0.309440092514644,0.199638769364287,"RB1/MAPK1/MAPK3",3
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PLCG1",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"GSK3B",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"AKT3",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PAK1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PAK1",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PLCG1",1
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PLCG1",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/45","16/2914",0.22093357142981,0.309440092514644,0.199638769364287,"PLCG1",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/45","59/2914",0.230916749036997,0.320589814919798,0.206832138657935,"CREB1/MAPK1",2
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/45","17/2914",0.233030876221273,0.320589814919798,0.206832138657935,"PLCG1",1
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/45","17/2914",0.233030876221273,0.320589814919798,0.206832138657935,"MDM2",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/45","17/2914",0.233030876221273,0.320589814919798,0.206832138657935,"MDM2",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/45","17/2914",0.233030876221273,0.320589814919798,0.206832138657935,"MAPK14",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/45","17/2914",0.233030876221273,0.320589814919798,0.206832138657935,"YY1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/45","61/2914",0.242440610067185,0.332067542906181,0.214237124455601,"PRKAA1/PRKAA2",2
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/45","18/2914",0.24494444562757,0.332067542906181,0.214237124455601,"PTEN",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/45","18/2914",0.24494444562757,0.332067542906181,0.214237124455601,"GSK3B",1
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","1/45","18/2914",0.24494444562757,0.332067542906181,0.214237124455601,"PLCG1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/45","18/2914",0.24494444562757,0.332067542906181,0.214237124455601,"EP300",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/45","62/2914",0.248214972826681,0.335523146408159,0.21646654606978,"MYB/TP53",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/45","19/2914",0.256677007763882,0.341303652694577,0.220195904964243,"EP300",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/45","19/2914",0.256677007763882,0.341303652694577,0.220195904964243,"AKT3",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/45","19/2914",0.256677007763882,0.341303652694577,0.220195904964243,"PLCG1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/45","19/2914",0.256677007763882,0.341303652694577,0.220195904964243,"GSK3B",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/45","19/2914",0.256677007763882,0.341303652694577,0.220195904964243,"EP300",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/45","114/2914",0.256895222458284,0.341303652694577,0.220195904964243,"MDM2/TP53/CDKN1A",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/45","20/2914",0.268231251166516,0.351345159978675,0.226674296760436,"MAPK14",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/45","20/2914",0.268231251166516,0.351345159978675,0.226674296760436,"MAPK1",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/45","20/2914",0.268231251166516,0.351345159978675,0.226674296760436,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/45","20/2914",0.268231251166516,0.351345159978675,0.226674296760436,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/45","20/2914",0.268231251166516,0.351345159978675,0.226674296760436,"EP300",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","5/45","228/2914",0.273768869319848,0.357591360207104,0.230704103359422,"MAPK14/VAV2/MAPK1/MAPK3/PAK1",5
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/45","21/2914",0.279609825353629,0.363180359747032,0.234309909514215,"AKT3",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/45","21/2914",0.279609825353629,0.363180359747032,0.234309909514215,"MAPK14",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/45","68/2914",0.282938760576167,0.366480567320105,0.23643907569039,"VAV2/PAK1",2
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"PLCG1",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"CDKN1A",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"SMAD3",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"MAPK14",1
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"PLCG1",1
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","1/45","22/2914",0.290815341378202,0.370490777372229,0.239026307982083,"PLCG1",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/45","23/2914",0.301850372373354,0.3814141933522,0.246073673130452,"SKI",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/45","23/2914",0.301850372373354,0.3814141933522,0.246073673130452,"MAPK14",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/45","23/2914",0.301850372373354,0.3814141933522,0.246073673130452,"STAT3",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/45","72/2914",0.306059725758479,0.38568502026475,0.248829045332097,"EP300/PAK1",2
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/45","24/2914",0.31271745409013,0.390896817612662,0.252191495233976,"EP300",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/45","24/2914",0.31271745409013,0.390896817612662,0.252191495233976,"PAK1",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/45","24/2914",0.31271745409013,0.390896817612662,0.252191495233976,"AKT3",1
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/45","25/2914",0.323419085427827,0.398912134546258,0.257362667449199,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/45","25/2914",0.323419085427827,0.398912134546258,0.257362667449199,"CREB1",1
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","1/45","25/2914",0.323419085427827,0.398912134546258,0.257362667449199,"PLCG1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/45","25/2914",0.323419085427827,0.398912134546258,0.257362667449199,"PLCG1",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/45","25/2914",0.323419085427827,0.398912134546258,0.257362667449199,"AKT3",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/45","76/2914",0.329065151890904,0.404802369389605,0.261162818961035,"NLK/TCF7L2",2
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/45","26/2914",0.333957728956988,0.408658799907893,0.263650838650254,"PRKAA2",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/45","26/2914",0.333957728956988,0.408658799907893,0.263650838650254,"PLCG1",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","8/45","428/2914",0.337561161512407,0.411984094759237,0.26579619016725,"CREB1/EP300/MAPK14/PLCG1/VAV2/MAPK1/MAPK3/PAK1",8
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/45","27/2914",0.344335811435152,0.416969146659754,0.269012352683712,"STAT5A",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/45","27/2914",0.344335811435152,0.416969146659754,0.269012352683712,"YY1",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/45","27/2914",0.344335811435152,0.416969146659754,0.269012352683712,"MYB",1
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/45","28/2914",0.354555724315449,0.423826251431063,0.273436291245847,"VAV2",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/45","28/2914",0.354555724315449,0.423826251431063,0.273436291245847,"SMAD3",1
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","1/45","28/2914",0.354555724315449,0.423826251431063,0.273436291245847,"PLCG1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/45","28/2914",0.354555724315449,0.423826251431063,0.273436291245847,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/45","28/2914",0.354555724315449,0.423826251431063,0.273436291245847,"EP300",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/45","82/2914",0.363207539668918,0.433055143451402,0.279390415129937,"SMAD3/STAT3",2
"R-HSA-977225","R-HSA-977225","Amyloid fiber formation","1/45","29/2914",0.36461982424816,0.433627156714564,0.27975945594488,"SIAH2",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/45","30/2914",0.374530433575312,0.440902915474734,0.284453493854667,"PTEN",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/45","30/2914",0.374530433575312,0.440902915474734,0.284453493854667,"GSK3B",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/45","30/2914",0.374530433575312,0.440902915474734,0.284453493854667,"TP53",1
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","1/45","30/2914",0.374530433575312,0.440902915474734,0.284453493854667,"PLCG1",1
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","4/45","202/2914",0.380473735075416,0.446768401035527,0.288237678087437,"MAPK1/MAPK3/PAK1/FOXO3",4
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/45","31/2914",0.384289840818415,0.450112785845247,0.290395345706611,"MAPK14",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/45","32/2914",0.393900301159439,0.456767182142492,0.294688504608059,"STAT3",1
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","1/45","32/2914",0.393900301159439,0.456767182142492,0.294688504608059,"PLCG1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/45","32/2914",0.393900301159439,0.456767182142492,0.294688504608059,"EP300",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/45","32/2914",0.393900301159439,0.456767182142492,0.294688504608059,"PLCG1",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/45","33/2914",0.403364036915104,0.46542004259435,0.300270995222162,"MAPK14",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/45","33/2914",0.403364036915104,0.46542004259435,0.300270995222162,"EP300",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/45","34/2914",0.412683238004594,0.471493134329573,0.304189118922305,"EP300",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/45","34/2914",0.412683238004594,0.471493134329573,0.304189118922305,"PAK1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/45","34/2914",0.412683238004594,0.471493134329573,0.304189118922305,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/45","34/2914",0.412683238004594,0.471493134329573,0.304189118922305,"TP53",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","2/45","92/2914",0.418668875487914,0.477159380151667,0.307844761388172,"MAPK1/MAPK3",2
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/45","35/2914",0.421860062410772,0.477286931924596,0.307927052854578,"HIPK2",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/45","35/2914",0.421860062410772,0.477286931924596,0.307927052854578,"GSK3B",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/45","35/2914",0.421860062410772,0.477286931924596,0.307927052854578,"TP53",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/45","37/2914",0.439795056145559,0.495954221452142,0.319970465452995,"EP300",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/45","157/2914",0.440492674106956,0.495954221452142,0.319970465452995,"EP300/TP53/YY1",3
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/45","38/2914",0.448557385820029,0.503814455087713,0.325041583927557,"PML",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/45","39/2914",0.457185660381259,0.512268270065748,0.330495658106934,"EP300",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/45","40/2914",0.465681884827466,0.520533837607624,0.335828282327499,"EP300",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/45","165/2914",0.473501267339484,0.52800501034259,0.340648393769413,"CREB1/MAPK1/MAPK3",3
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/45","42/2914",0.48228605728281,0.532691250918068,0.34367177478585,"TCF7L2",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/45","42/2914",0.48228605728281,0.532691250918068,0.34367177478585,"VAV2",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/45","42/2914",0.48228605728281,0.532691250918068,0.34367177478585,"MAPK14",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/45","42/2914",0.48228605728281,0.532691250918068,0.34367177478585,"STAT3",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/45","296/2914",0.487790381867629,0.537494141157458,0.346770413649973,"PLCG1/SIAH2/AKT3/PAK1/PTEN",5
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/45","43/2914",0.490397870452125,0.539089857589215,0.347799908122074,"PTEN",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/45","44/2914",0.498385364645665,0.545292222494669,0.351801433867528,"STAT5A",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/45","44/2914",0.498385364645665,0.545292222494669,0.351801433867528,"PLCG1",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/45","45/2914",0.506250402482231,0.551062426125744,0.355524145887577,"STAT5A",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/45","109/2914",0.507214448132943,0.551062426125744,0.355524145887577,"EP300/CLOCK",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/45","109/2914",0.507214448132943,0.551062426125744,0.355524145887577,"EP300/CLOCK",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/45","46/2914",0.513994819313287,0.555831606931811,0.3586010367302,"YY1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/45","46/2914",0.513994819313287,0.555831606931811,0.3586010367302,"TP53",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/45","47/2914",0.521620423612765,0.560169738983685,0.361399831602378,"PML",1
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","1/45","47/2914",0.521620423612765,0.560169738983685,0.361399831602378,"STAT3",1
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","1/45","47/2914",0.521620423612765,0.560169738983685,0.361399831602378,"STAT3",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/45","48/2914",0.529128997361431,0.565620652351875,0.364916549904435,"MAPK14",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","1/45","48/2914",0.529128997361431,0.565620652351875,0.364916549904435,"VAV2",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/45","51/2914",0.550969965634819,0.582275077318615,0.375661340205558,"EP300",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/45","51/2914",0.550969965634819,0.582275077318615,0.375661340205558,"EP300",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/45","51/2914",0.550969965634819,0.582275077318615,0.375661340205558,"EP300",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/45","51/2914",0.550969965634819,0.582275077318615,0.375661340205558,"EP300",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/45","51/2914",0.550969965634819,0.582275077318615,0.375661340205558,"EP300",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/45","188/2914",0.563319446089499,0.593976286693009,0.383210507543877,"MAPK1/MAPK3/STAT5A",3
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/45","55/2914",0.578556453676923,0.608662332488166,0.392685375798817,"GSK3B",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/45","125/2914",0.582502311662565,0.611430191699984,0.394471091419344,"MAPK14/MAPK1",2
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/45","61/2914",0.616855540813598,0.644579385344546,0.415857667964223,"VAV2",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/45","61/2914",0.616855540813598,0.644579385344546,0.415857667964223,"VAV2",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/45","62/2914",0.622898828813384,0.647982003128016,0.418052905243882,"STAT3",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/45","62/2914",0.622898828813384,0.647982003128016,0.418052905243882,"TP53",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/45","64/2914",0.634707107643211,0.657324732859895,0.424080472812836,"EP300",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/45","64/2914",0.634707107643211,0.657324732859895,0.424080472812836,"PAK1",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/45","66/2914",0.646153594942828,0.667692048107589,0.430769063295219,"EP300",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","2/45","144/2914",0.660879757644873,0.681394872072874,0.439609594885725,"AKT3/PRKAA2",2
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/45","69/2914",0.662668593292453,0.681727645754404,0.439824287583487,"PLCG1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","6/45","436/2914",0.68513294036824,0.703282157331637,0.453730424084927,"CREB1/VAV2/AKT3/MAPK1/MAPK3/PAK1",6
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/45","76/2914",0.69832765278133,0.715247485778235,0.461449990824668,"VAV2",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","2/45","160/2914",0.717649284595483,0.733421796344834,0.473175352480538,"AKT3/PRKAA2",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","1/45","81/2914",0.721513886983953,0.735754292648109,0.474680188805232,"TP53",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/45","88/2914",0.751071359824873,0.763514325482869,0.492589887408303,"SIAH2",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","2/45","171/2914",0.752020561443342,0.763514325482869,0.492589887408303,"MAPK1/MAPK3",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","2/45","177/2914",0.769254963147846,0.779310583581151,0.502781021665259,"MAPK1/MAPK3",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","6/45","486/2914",0.785971003014058,0.794514166090298,0.512589784574386,"CREB1/VAV2/AKT3/MAPK1/MAPK3/PAK1",6
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/45","106/2914",0.813700463315001,0.818984232557306,0.52837692423052,"VAV2",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/45","106/2914",0.813700463315001,0.818984232557306,0.52837692423052,"VAV2",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/45","109/2914",0.822517491689937,0.826070483014732,0.532948698719182,"MAPK14",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/45","115/2914",0.838944729716783,0.840752800254965,0.542421161454816,"SIAH2",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/45","217/2914",0.86006429703549,0.86006429703549,0.5548801916358,"CREB1/MAPK1",2
